Champions Oncology: Q3 Earnings Insights
Champions Oncology: Q3 Earnings Insights
Champions Oncology (NASDAQ:CSBR) reported its Q3 earnings results on Tuesday, March 12, 2024 at 04:00 PM.
Champions Oncology（納斯達克股票代碼：CSBR）於2024年3月12日星期二下午4點公佈了其第三季度業績。
Here's what investors need to know about the announcement.
以下是投資者需要了解的有關該公告的信息。
Earnings
收益
Champions Oncology missed estimated earnings by -7.000000000000001%, reporting an EPS of $-0.16 versus an estimate of $-0.15.
Champions Oncology報告每股收益爲-0.16美元，低於預期收益-7.00000000001％，而估計爲-0.15美元。
Revenue was down $754 thousand from the same period last year.
收入比去年同期下降了75.4萬美元。
Past Earnings Performance
過去的收益表現
Last quarter the company beat on EPS by $0.02 which was followed by a 5.0% increase in the share price the next day.
上個季度，該公司的每股收益高出0.02美元，隨後第二天股價上漲了5.0％。
Here's a look at Champions Oncology's past performance:
以下是 Champions Oncology 過去的表現：
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.17 | -0.10 | -0.12 | -0.03 |
| EPS Actual | -0.15 | -0.16 | -0.17 | -0.16 |
| Revenue Estimate | 12.84M | 13.06M | 12.86M | 13.13M |
| Revenue Actual | 11.57M | 12.56M | 13.07M | 12.77M |
| 季度 | 2024 年第二季度 | 2024 年第一季度 | 2023 年第四季度 | 2023 年第三季度 |
|---|---|---|---|---|
| 每股收益估算 | -0.17 | -0.10 | -0.12 | -0.03 |
| 實際每股收益 | -0.15 | -0.16 | -0.17 | -0.16 |
| 收入估算 | 12.84 億 | 13.06M | 12.86 米 | 13.13 米 |
| 實際收入 | 11.57 億 | 12.56 米 | 13.07 米 | 12.77M |
To track all earnings releases for Champions Oncology visit their earnings calendar here.
要追蹤Champions Oncology的所有業績，請在此處訪問他們的業績日曆。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成，並由編輯審閱。
譯文內容由第三人軟體翻譯。